Developing porosity of poly(propylene glycol-co-fumaric acid) bone graft substitutes and the effect on osteointegration: a preliminary histology study in rats.
Bioresorbable bone graft substitutes could eliminate disadvantages associated with the use of autografts, allografts and other synthetic materials. We investigated a bioresorbable bone graft substitute made from the unsaturated polyester poly(propylene fumarate) which is crosslinked in the presence of soluble and insoluble calcium filler salts. This compact bone graft substitute material develops porosity in vivo by leaching of the soluble filler salts. In attempt to develop materials whose in vivo porosity can be designed such that implant degradation would occur at a rate that remains supportive of the overall structural integrity of the repairing defect site, we studied the early tissue response upon implantation in a bony defect. Three grout formulations of varying solubilities using slightly soluble hydroxyapatite (HA) and soluble calcium acetate (CA) were evaluated in 3 mm holes made in the anteromedial tibial metaphysis of 200 g Sprague Dawley rats (n = 16 per formulation for a total of 48 animals). Grout formulations cured in situ. Animals from each formulation were sacrificed in groups of 8 at 4 days and 3 weeks postoperatively. Histologic analysis of the healing process revealed improved in vivo osteointegration of bone graft substitutes when a higher loading of calcium acetate was employed. All formulations maintained implant integrity and did not provoke sustained inflammatory responses. This study suggested that the presence of a soluble salt permits in vivo development of porosity of a poly(propylene fumarate) based bone graft substitute material.
Lewandrowski
K U
KU
Orthopaedic Research Laboratories, Massachusetts General Hospital, Boston 02114, USA.
Gresser
J D
JD
Bondre
S
S
Silva
A E
AE
Wise
D L
DL
Trantolo
D J
DJ
D000085:Acetates / Q000737:chemistry / Q000494:pharmacology; D000818:Animals; D001846:Bone Development / Q000502:physiology; D016025:Bone Transplantation / Q000379:methods*; D001842:Bone and Bones / Q000737:chemistry / Q000502:physiology*; D002118:Calcium / Q000737:chemistry; D017610:Calcium Compounds; D017886:Durapatite / Q000737:chemistry; D007700:Kinetics; D008297:Male; D011108:Polymers / Q000494:pharmacology*; D011409:Propylene Glycols / Q000494:pharmacology*; D019736:Prostheses and Implants; D051381:Rats; D017207:Rats, Sprague-Dawley; D013977:Tibia / Q000737:chemistry / Q000473:pathology; D013997:Time Factors
D000085:Acetates; D017610:Calcium Compounds; D011108:Polymers; D011409:Propylene Glycols; C106431:poly(propylene glycol-fumarate); D017886:Durapatite; D002118:Calcium; C120662:calcium acetate